Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter van Elmpt

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|March 17, 2023
Automatic quality assurance of radiotherapy treatment plans using Bayesian networks: A multi-institutional studyPetros Kalendralis, Samuel M H Luk, Richard Canters, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancerSara Carvalho, Ralph T H Leijenaar, Emmanuel Rios Velazquez, et al.
Journal of Neuro-Oncology|December 14, 2023
Anatomical changes in resection cavity during brain radiotherapyYves C P Willems, Femke Vaassen, Catharina M L Zegers, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancerEvelyn E C de Jong, Wouter van Elmpt, Stefania Rizzo, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 5, 2020
Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fieldsWillem J Koemans, Ruben T H M Larue, Maximilian Kloft, et al.
The British Journal of Radiology|July 26, 2023
Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patientsVicki Trier Taasti, Esther Decabooter, Daniëlle Eekers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancerSofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
Journal of the National Cancer Center|July 22, 2024
Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675)Oscar Candiff, José Belderbos, Anne Lisa Wolf, et al.
Plos One|June 4, 2019
Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomicsJanna E van Timmeren, Sara Carvalho, Ralph T H Leijenaar, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|March 17, 2023
Automatic quality assurance of radiotherapy treatment plans using Bayesian networks: A multi-institutional studyPetros Kalendralis, Samuel M H Luk, Richard Canters, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancerSara Carvalho, Ralph T H Leijenaar, Emmanuel Rios Velazquez, et al.
Journal of Neuro-Oncology|December 14, 2023
Anatomical changes in resection cavity during brain radiotherapyYves C P Willems, Femke Vaassen, Catharina M L Zegers, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancerEvelyn E C de Jong, Wouter van Elmpt, Stefania Rizzo, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 5, 2020
Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fieldsWillem J Koemans, Ruben T H M Larue, Maximilian Kloft, et al.
The British Journal of Radiology|July 26, 2023
Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patientsVicki Trier Taasti, Esther Decabooter, Daniëlle Eekers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancerSofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
Journal of the National Cancer Center|July 22, 2024
Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675)Oscar Candiff, José Belderbos, Anne Lisa Wolf, et al.
Plos One|June 4, 2019
Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomicsJanna E van Timmeren, Sara Carvalho, Ralph T H Leijenaar, et al.
Pageof 16